David W Beier's Net Worth
$17.8 Million
Who is David W Beier?
David W Beier has an estimated net worth of $17.8 Million. This is based on reported shares across multiple companies, which include AMGEN INC, ARYx Therapeutics, Inc., Arcus Biosciences, Inc., INFINITY PHARMACEUTICALS, INC., and VAXGEN INC.
SEC CIK
David W Beier's CIK is 0001187054
Past Insider Trading and Trends
2012 was David W Beier's most active year for acquiring shares with 12 total transactions. David W Beier's most active month to acquire stocks was the month of March. 2012 was David W Beier's most active year for disposing of shares, totalling 17 transactions. David W Beier's most active month to dispose stocks was the month of March. 2010 saw David W Beier paying a total of $2,337,200.00 for 57,206 shares, this is the most they've acquired in one year. In 2012 David W Beier cashed out on 269,872 shares for a total of $9,544,184.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMGEN INC (AMGN) Snapshot price: $320.56
SVP, Global Govt Affairs
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$63.31 | -$815,619.00 | 35.61K |
May 3
| |||
Form 4
| +4.24% | 1.45K |
$71.64 | -$136,187.64 | 35.61K |
Apr 27 - Apr 29
| |||
Form 4
| -1.85% | -645.00 |
$70.19 | -$45,272.55 | 34.16K |
Apr 26
| |||
Form 4
| -6.26% | -2.33K |
$68.26 | -$158,772.76 | 34.81K |
Mar 16
| |||
Form 4
| +16.40% | 5.23K |
—
|
—
| 37.13K |
Mar 14
| |||
Form 4
|
—
|
0
|
$61.66 | -$288,978.00 | 31.9K |
Feb 7
| |||
Form 4
|
—
|
0
|
$58.53 | -$1,142,929.25 | 31.9K |
Jan 27
| |||
Form 4
| -31.98% | -15.00K |
$51.56 | -$773,470.50 | 31.9K |
Aug 15
| |||
Form 4
| -3.71% | -1.81K |
$57.04 | -$103,186.74 | 46.9K |
Apr 28 - Apr 29
| |||
Form 4
| +16.81% | 7.01K |
$54.69 | -$26,798.10 | 48.71K |
Apr 25 - Apr 26
| |||
Form 4
| -6.37% | -2.83K |
$51.84 | -$146,966.40 | 41.7K |
Mar 11
| |||
Form 4
| +23.23% | 8.39K |
—
|
—
| 44.54K |
Mar 2
| |||
Form 4
| -26.45% | -13.00K |
$54.94 | -$714,220.00 | 36.14K |
Aug 13
| |||
Form 4
| -18.40% | -11.08K |
$54.53 | -$604,246.93 | 49.14K |
Jul 31
| |||
Form 4
| -2.37% | -1.47K |
$58.07 | -$85,066.76 | 60.22K |
Apr 28 - Apr 29
| |||
Form 4
| +10.38% | 5.8K |
—
|
—
| 61.69K |
Apr 26
| |||
Form 4
| +5.95% | 3.14K |
$57.49 | -$92,156.47 | 55.89K |
Mar 12
| |||
Form 4
| -11.54% | -6.88K |
$50.43 | -$347,140.16 | 52.75K |
Jun 3
| |||
Form 4
| +9.21% | 4.95K |
$47.63 | -$115,979.05 | 58.72K |
May 7 - May 8
| |||
Form 4
| -1.68% | -918.00 |
$50.44 | -$46,303.92 | 53.76K |
Apr 29
| |||
Form 4
|
∞
| 5.7K |
—
|
—
| 5.7K |
Apr 28
| |||
Form 4
| -5.53% | -2.92K |
$52.88 | -$154,417.20 | 49.9K |
Oct 23
| |||
Form 4
| -14.56% | -9.00K |
$43.01 | -$387,099.00 | 52.82K |
May 27
| |||
Form 4
| -6.87% | -4.56K |
$41.86 | -$190,756.02 | 61.82K |
May 12
| |||
Form 4
| +27.10% | 14.15K |
—
|
—
| 66.38K |
May 7
| |||
Form 4
| +27.92% | 11.4K |
—
|
—
| 52.22K |
Apr 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARYx Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcus Biosciences, Inc. (RCUS) Snapshot price: $15.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INFINITY PHARMACEUTICALS, INC. (INFIQ) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +53.57% | 3.06K |
$3.43 | $10,499.23 | 8.78K |
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
∞
| 5.71K |
$1.75 | $9,999.50 | 5.71K |
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VAXGEN INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
| No matching records found | |||||||||